BioSpace News Archive

The National Council of Self-Insurers asked Joe Paduda to discuss how medical providers price their services to different payer groups at its 2019 Annual Meeting, June 9-12.

Breakthrough in industrial large-scale manufacturing of well-defined biomedical fiber-based scaffolds for a wide variety of medical applications

Findings in molecular science will advance and reinvent cancer care for patients

Choom™, is pleased to announce that Specialty Medijuana Products Inc., of which Choom Holdings Inc.

Anixa Biosciences, Inc. announced that it will be presenting at the Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum to be held May 31, 2019 in Chicago.

Cellect Biotechnology Ltd., a developer of innovative technology which enables the functional selection of stem cells, reported financial and operating results for the first quarter ended March 31, 2019 and provided a corporate update.

Purdue Veterinary Medicine Researchers Document Benefits of Service Dogs for Recipients and Family Members

Sesen Bio announced that the Company has completed its Type C CMC meeting and has reached agreement with the U.S. Food and Drug Administration on the Analytical Comparability Plan, and that, subject to final comparability data to be provided in the BLA submission, no additional clinical trials to establish comparability are deemed necessary at this time.

HLS-CATCH method extracts high molecular weight DNA and uses Cas9 nucleases to purify large genomic regions for deep sequencing of gene targets

Dr Mark Albertella appointed VP Translational Oncology